125
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study

&
Pages 489-496 | Published online: 29 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Annika Kragh Ekstam & Pia Andersson. (2023) Oral Health Status Using the Revised Oral Assessment Guide and Mortality in Older Orthopaedic Patients: A Cross-Sectional Study. Clinical Interventions in Aging 18, pages 1103-1113.
Read now
Pia Andersson & Annika Kragh Ekstam. (2021) Impaired Oral Health in Older Orthopaedic In-Care Patients: The Influence of Medication and Morbidity. Clinical Interventions in Aging 16, pages 1691-1702.
Read now

Articles from other publishers (14)

Mahin Delara, Lauren Murray, Behnaz Jafari, Anees Bahji, Zahra Goodarzi, Julia Kirkham, Mohammad Chowdhury & Dallas P. Seitz. (2022) Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatrics 22:1.
Crossref
Thomas Münzer. 2022. Senior Trauma Patients. Senior Trauma Patients 143 147 .
Shinya Toriumi, Akinobu Kobayashi, Hitoshi Sueki, Munehiro Yamamoto & Yoshihiro Uesawa. (2021) Exploring the Mechanisms Underlying Drug-Induced Fractures Using the Japanese Adverse Drug Event Reporting Database. Pharmaceuticals 14:12, pages 1299.
Crossref
Jiyoon Han & Eunok Park. (2021) Medications and Falls Experiences among Older People. Journal of Korean Gerontological Nursing 23:4, pages 373-383.
Crossref
Amy L. Shaver, Collin M. Clark, Mary Hejna, Steven Feuerstein, Robert G. WahlerJr.Jr. & David M. Jacobs. (2021) Trends in fall‐related mortality and fall risk increasing drugs among older individuals in the United States,1999–2017 . Pharmacoepidemiology and Drug Safety 30:8, pages 1049-1056.
Crossref
Noelle Probert, A. Lööw, G. Akner, P. Wretenberg & Å. G. Andersson. (2020) A Comparison of Patients with Hip Fracture, Ten Years Apart: Morbidity, Malnutrition and Sarcopenia. The journal of nutrition, health & aging 24:8, pages 870-877.
Crossref
Johannes Gleich, Daniel Pfeufer, Christian Zeckey, Wolfgang Böcker, Markus Gosch, Christian Kammerlander & Carl Neuerburg. (2019) Orthogeriatric treatment reduces potential inappropriate medication in older trauma patients: a retrospective, dual-center study comparing conventional trauma care and co-managed treatment. European Journal of Medical Research 24:1.
Crossref
Susanne Schiek, Katja Hildebrandt, Olaf Zube & Thilo Bertsche. (2019) Fall-risk-increasing adverse reactions—is there value in easily accessible drug information? A case-control study. European Journal of Clinical Pharmacology 75:6, pages 849-857.
Crossref
A. Etangsale & R. Ratiney. (2019) Médicaments et chutes chez les personnes âgées : une étude épidémiologique dans un hôpital français. Le Pharmacien Hospitalier et Clinicien 54:1, pages 38-48.
Crossref
I. J. A. de Bruin, C. Klop, C. E. Wyers, J. A. Overbeek, P. P. M. M. Geusens, J. P. W. van den Bergh, J. H. M. Driessen & F. de Vries. (2019) All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture. Osteoporosis International 30:3, pages 573-581.
Crossref
Hae-Young Park, Suji Kim, Hyun Soon Sohn & Jin-Won Kwon. (2018) The Association between Polypharmacy and Hip Fracture in Osteoporotic Women: A Nested Case–Control Study in South Korea. Clinical Drug Investigation 39:1, pages 63-71.
Crossref
Andrea Iaboni, Kerri Rawson, Craig Burkett, Eric J. Lenze & Alastair J. Flint. (2017) Potentially Inappropriate Medications and the Time to Full Functional Recovery After Hip Fracture. Drugs & Aging 34:9, pages 723-728.
Crossref
Tom MunyerSydney P. Springer & Megan Carr. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
E. Bambina, E. Mestivier & T. Berod. (2017) Chutes et identification des facteurs de risques médicamenteux chez le sujet âgé : apport du bilan médicamenteux optimisé à l’entrée d’hospitalisation. Le Pharmacien Hospitalier et Clinicien 52:1, pages 21-25.
Crossref